I posted a reply in a different thread to you on this 'other ASX stock that you don't want to cross-promote' but keep mentioning in AT1 threads for some reason?..that 'other'ASX stock is several months away from putting out a commercially produced RDT (which will still require TGA approval) & begin manufacturing scaleup too.
Access Bio, AT1's USA partner, has an antigen test - lab based not RDT. If its possible, no doubt Access Bio will be looking to make a test strip for it too...like they have for antibody tests..but antigen tests are still not close enough in accuracy for a portable test device. Lab based, sure, already many on market at 100% accuracy.
Ann: Atomo & Access Bio enter North American COVID-19 partnership, page-158
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.14M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 777274 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 431397 | 5 |
View Market Depth
| Last trade - 12.59pm 18/09/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |
Day chart unavailable